Naomi Murakami Selected Research

Naomi Murakami Research Topics

Disease

3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2015 - 03/2005
3	Leukemia 01/2015 - 04/2003
3	Chromosome Aberrations (Chromosome Abnormalities) 05/2010 - 03/2005
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2010 - 02/2002
2	Disease Progression 01/2016 - 05/2010
2	Thrombocytopenia (Thrombopenia) 01/2014 - 05/2010
2	Neoplasms (Cancer) 03/2013 - 08/2006
2	Disseminated Intravascular Coagulation 11/2012 - 04/2007
1	Fecal Impaction 08/2018
1	Constipation 08/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2015
1	Purpura 01/2014
1	Gray Platelet Syndrome 01/2014
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2014
1	Liver Diseases (Liver Disease) 11/2012
1	Febrile Neutropenia 05/2012
1	Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases) 05/2012
1	Leukocytosis (Pleocytosis) 05/2010
1	Tetraploidy 05/2010
1	Pancytopenia 04/2007
1	Tumor Lysis Syndrome 08/2006
1	Vomiting 08/2006
1	Multiple Myeloma 08/2006
1	Fever (Fevers) 08/2006
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 08/2006
1	Hemorrhage 04/2006
1	Hemophilia A (Haemophilia) 04/2006
1	Ischemic Colitis 04/2006
1	Acute Promyelocytic Leukemia 07/2005
1	Hematoma 04/2005
1	Burkitt Lymphoma (Burkitt's Lymphoma) 04/2005
1	Hemiplegia (Spastic Hemiplegia) 04/2005
1	Subdural Hematoma (Subdural Hemorrhage) 04/2005
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2005
1	Blast Crisis (Blast Phase) 03/2005
1	Philadelphia Chromosome 03/2005
1	Hypercalcemia (Milk Alkali Syndrome) 02/2002
1	Splenomegaly 02/2002

Drug/Important Bio-Agent (IBA)

2	Imatinib Mesylate (Gleevec)FDA Link 05/2010 - 03/2005
1	LaxativesIBA 08/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 08/2018
1	SodiumIBA 08/2018
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2015
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2015
1	Core Binding Factors (Core-Binding Factor)IBA 01/2015
1	Inosine Triphosphate (ITP)IBA 01/2014
1	Immunoglobulin G (IgG)IBA 01/2014
1	Interleukin-6 (Interleukin 6)IBA 11/2012
1	Cefepime (Maxipime)FDA LinkGeneric 05/2012
1	p 230 (p230)IBA 05/2010
1	Dacarbazine (DIC)FDA LinkGeneric 04/2007
1	Bortezomib (Velcade)FDA Link 08/2006
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 04/2006
1	Blood Coagulation Factors (Coagulation Factor)IBA 04/2006
1	Factor VIII (Coagulation Factor VIII)IBA 04/2006
1	prothrombin complex concentrates (PPSB)IBA 04/2006
1	Factor VIIa (Activated Factor VII)IBA 04/2006
1	Arsenic Trioxide (Trisenox)FDA Link 07/2005
1	LigandsIBA 05/2005
1	Immunoglobulins (Immunoglobulin)IBA 04/2005
1	Phosphotransferases (Kinase)IBA 03/2005
1	nuclear pore complex protein 98IBA 03/2005
1	bcr-abl Fusion ProteinsIBA 03/2005
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2004
1	Retinoic Acid Receptor alphaIBA 03/2004
1	HLA-DR Antigens (HLA-DR)IBA 04/2003
1	Prednisolone (Predate)FDA LinkGeneric 02/2002
1	Vincristine (Oncovin)FDA LinkGeneric 02/2002
1	Vindesine (Vindesin)IBA 02/2002
1	Hydroxyurea (Hydrea)FDA LinkGeneric 02/2002
1	cimadronateIBA 02/2002
1	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2002
1	Parathyroid Hormone-Related ProteinIBA 02/2002

Therapy/Procedure

5	Therapeutics 01/2015 - 03/2005
2	Drug Therapy (Chemotherapy) 04/2005 - 02/2002
1	Transplantation 01/2016
1	Chemoradiotherapy 01/2015
1	Palliative Care (Palliative Therapy) 03/2013
1	Stem Cell Transplantation 08/2006